Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Cosma

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Clinical Chemistry and Laboratory Medicine|April 15, 2021
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titersAndrea Padoan, Francesco Bonfante, Chiara Cosma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 20, 2014
Cystatin C and risk of mortality among patients undergoing percutaneous coronary interventionFabio Angeli, Paolo Verdecchia, Stefano Savonitto, et al.
Cancer Biomarkers : Section a of Disease Markers|July 6, 2020
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinomaGabriele Ricco, Chiara Cosma, Giorgio Bedogni, et al.
Clinical Chemistry and Laboratory Medicine|December 15, 2021
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassaysAndrea Padoan, Chiara Cosma, Francesco Bonfante, et al.
Cancer Biomarkers : Section a of Disease Markers|December 28, 2017
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkersGabriele Ricco, Daniela Cavallone, Chiara Cosma, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 10, 2021
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assaysAndrea Padoan, Chiara Cosma, Francesco Bonfante, et al.
BMC Medicine|February 24, 2022
The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic waveDaniela Basso, Ada Aita, Filippo Navaglia, et al.
Hepatology (Baltimore, Md.)|September 20, 2022
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injuryCarmine Gambino, Salvatore Piano, Matteo Stenico, et al.
Diabetes|June 23, 2010
The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healingGian Paolo Fadini, Mattia Albiero, Lisa Menegazzo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 23, 2024
Blood biomarkers for Alzheimer's disease with the Lumipulse automated platform: Age-effect and clinical value interpretationGiulia Musso, Carlo Gabelli, Marco Puthenparampil, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Clinical Chemistry and Laboratory Medicine|April 15, 2021
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titersAndrea Padoan, Francesco Bonfante, Chiara Cosma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 20, 2014
Cystatin C and risk of mortality among patients undergoing percutaneous coronary interventionFabio Angeli, Paolo Verdecchia, Stefano Savonitto, et al.
Cancer Biomarkers : Section a of Disease Markers|July 6, 2020
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinomaGabriele Ricco, Chiara Cosma, Giorgio Bedogni, et al.
Clinical Chemistry and Laboratory Medicine|December 15, 2021
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassaysAndrea Padoan, Chiara Cosma, Francesco Bonfante, et al.
Cancer Biomarkers : Section a of Disease Markers|December 28, 2017
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkersGabriele Ricco, Daniela Cavallone, Chiara Cosma, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 10, 2021
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assaysAndrea Padoan, Chiara Cosma, Francesco Bonfante, et al.
BMC Medicine|February 24, 2022
The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic waveDaniela Basso, Ada Aita, Filippo Navaglia, et al.
Hepatology (Baltimore, Md.)|September 20, 2022
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injuryCarmine Gambino, Salvatore Piano, Matteo Stenico, et al.
Diabetes|June 23, 2010
The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healingGian Paolo Fadini, Mattia Albiero, Lisa Menegazzo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 23, 2024
Blood biomarkers for Alzheimer's disease with the Lumipulse automated platform: Age-effect and clinical value interpretationGiulia Musso, Carlo Gabelli, Marco Puthenparampil, et al.
Pageof 8